Hinge Health, Inc. HNGE
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 49.76% | 49.78% | 50.58% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.76% | 49.78% | 50.58% | -- | -- |
| Cost of Revenue | 4.44% | 37.59% | 30.97% | -- | -- |
| Gross Profit | 62.67% | 52.96% | 56.50% | -- | -- |
| SG&A Expenses | -32.96% | 186.84% | 179.88% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 94.51% | -- | -- | -- | -- |
| Total Operating Expenses | -39.26% | 180.21% | 168.56% | -- | -- |
| Operating Income | 117.02% | -4,275.75% | -1,611.15% | -- | -- |
| Income Before Tax | 120.93% | -1,635.11% | -4,584.27% | -- | -- |
| Income Tax Expenses | 126.75% | -46.21% | 47.71% | -- | -- |
| Earnings from Continuing Operations | 120.54% | -1,711.22% | -4,326.89% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 120.54% | -1,711.22% | -4,326.89% | -- | -- |
| EBIT | 117.02% | -4,275.75% | -1,611.15% | -- | -- |
| EBITDA | 117.45% | -3,632.86% | -1,739.89% | -- | -- |
| EPS Basic | 142.38% | -237.45% | -407.59% | -- | -- |
| Normalized Basic EPS | 114.16% | -640.64% | -1,213.21% | -- | -- |
| EPS Diluted | 113.15% | -627.17% | -1,103.40% | -- | -- |
| Normalized Diluted EPS | 112.17% | -1,074.73% | -1,298.49% | -- | -- |
| Average Basic Shares Outstanding | 264.93% | 400.06% | 301.33% | -- | -- |
| Average Diluted Shares Outstanding | 97.18% | 112.16% | 424.68% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |